The global
particle therapy equipment market (mainly proton therapy devices) showed an average annual growth rate of almost 14% from 2000 to 2017.
Particle therapy is being noticed as one of the effective treatment methods due to the side effects of treatment are few compared with other cancer treatment methods such as surgical treatment and rehabilitation after treatment is also relatively fast.
25 ( ANI ): Researchers have recently found that proton beam therapy is a type of
particle therapy that uses a beam of protons to irradiate diseased tissue and in combination with chemotherapy may be effective for treating esophageal cancer in elderly patients.
Companies Mentioned in this Report: Hitachi, IBA Proton Therapy, Mitsubishi Electric, Varian Medical Systems, Accuray, Advanced Oncotherapy, Advanced
Particle Therapy, Advanced Proton Solutions, Best
Particle Therapy, Compact Particle Acceleration, Elekta, GE Healthcare, Mevion Medical Systems, Optivus ProtonTherap, Procure Treatment Center, ProNova Solutions, ProTom International, SAH Global, Siemens, Sumitomo Heavy Industries, Toshiba
There are currently 43
particle therapy facilities in the world, almost a third of which are in America.
Other topics include accelerators for proton and ion therapy, requirements for
particle therapy facilities, image-guided therapy, conformal proton therapy, and future prospects for
particle therapy.
LHC, RHIC, Tevatron), particle accelerators are used in a large variety of applications, including
particle therapy for oncological purposes, and as synchrotron light sources for fields such as condensed matter physics.
There have been exciting new developments in the technologies of other radiation modalities including proton
particle therapy, and in the concurrent use of radiation with biological therapy and chemotherapy.
Proton therapy is a type of
particle therapy which uses a beam of protons to irradiate diseased tissue, most often in the treatment of cancer.
A section on charged
particle therapy reviews the biology and physics of charged particles, explains the technology for
particle therapy, describes clinical experience, and discusses ways to incorporate the emerging technology into routine medical care in the US.
Located 30 miles west of Chicago on a 15-acre technology park site, the center will be a world-class facility not only for the treatment of cancer, but also for research and professional training in the growing field of
particle therapy.
As an initial step, the TBMF proceeds with a plan of establishing the Tokyo Bay Medical Frontier Center, a shared facility that will provide the cutting-edge cancer treatments such as heavy
particle therapy and immune cell therapy.
